Facilitating Innovative Nuclear Diagnostics Act of 2023
United States118th CongressHR-1199House of Representatives
Updated: May 16, 2024
Summary
Facilitating Innovative Nuclear Diagnostics Act of 2023 This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2024 and as adjusted based on a specified fee schedule factor in each year thereafter.
Bill texts
All available records shown.
Timeline
Latest companion bill action
S-1544: Facilitating Innovative Nuclear Diagnostics Act of 2023Introduced in Senate
Introduced in House
Referred to the Subcommittee on Health.
House of Representatives
Subcommittee Consideration and Mark-up Session Held
House of Representatives
Forwarded by Subcommittee to Full Committee by Voice Vote.
House of Representatives